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Abstract
International infectious disease surveillance has been conducted by the United States (U.S.) Department of Defense
(DoD) for many years and has been consolidated within the Armed Forces Health Surveillance Center, Division of
Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) since 1998. This includes activities that
monitor the presence of antimicrobial resistance among pathogens. AFHSC-GEIS partners work within DoD military
treatment facilities and collaborate with host-nation civilian and military clinics, hospitals and university systems.
The goals of these activities are to foster military force health protection and medical diplomacy. Surveillance
activities include both community-acquired and health care-associated infections and have promoted the
development of surveillance networks, centers of excellence and referral laboratories. Information technology
applications have been utilized increasingly to aid in DoD-wide global surveillance for diseases significant to force
health protection and global public health. This section documents the accomplishments and activities of the
network through AFHSC-GEIS partners in 2009.
Introduction and background
Antimicrobial resistance is a growing threat to the con-
trol of infectious disease globally and within the United
States. Lethal organisms once thought to be on the
decline are re-emerging with resistance to commonly
used antimicrobials. Resistant organisms once acquired
exclusively in hospital settings are now widely circulat-
ing in communities. Infections with resistant organisms
not only result in greater severity and higher rates of
morbidity and mortality, but also increase health care
treatment costs and long-range expenses related to
research and development of new drugs.
Since its inception, AFHSC-GEIS has a legacy of anti-
microbial resistance surveillance. This activity continues
as one of the five key focus areas for AFHSC-GEIS.
Although few of the annual AFHSC-GEIS-funded pro-
posals are singularly devoted to antimicrobial resistance,
over several years the organization’s partners have
developed diverse surveillance programs that often
involve studies of microbial sensitivities to antibiotics.
Many of these projects include outcomes that not only
direct appropriate use of antimicrobials for individual
patients and regional health planners, but are also
aligned with DoD efforts of medical diplomacy with
capacity building and investments in outbreak detection
and response. These activities often involve collabora-
tions with the host-nation civilian and military clinics
and hospitals, as well as university systems. Other anti-
microbial resistance-related programs represent colla-
borations within DoD for identification and tracking of
infections at military medical facilities. Taken together,
these activities are beneficial to both force health pro-
tection and the host nation in many interconnected
levels. The following is a synopsis of selected partner
activities from 2009.
2009 contributions
Pathogens in Southeast Asia
Over the last several years, a dramatic rise in antibiotic
resistance of enteric pathogens, including enterotoxigenic
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pylobacter has been documented in Southeast and South
Asia [1]. Many hospitals and laboratories in this region
lacked the essential infrastructure and capability to iso-
late and identify enteric pathogens and to reliably test
antimicrobial resistance. Several U.S. Naval Medical
Research Unit Number 2 (NAMRU-2) projects involved
laboratory-based microbiologic surveillance of patients
presenting for the care of febrile illnesses in host-nation
civilian and military clinics and hospitals scattered
around the regions. These efforts not only help deter-
mine the etiology of febrile illnesses and antimicrobial
sensitivity patterns in these areas but also provide essen-
tial host-nation laboratory capacity building and training.
In an effort to determine the epidemiology and etiolo-
gies of acute febrile illness of unknown origin among
persons seeking medical care in Cambodia, NAMRU-
2 established a five-year hospital-based surveillance
study commencing in December 2006. Depending on
the patients’ presenting complaints, nasal/throat swabs,
serum samples, blood cultures, malaria smears and stool
samples were obtained from 4,751 patients with fever at
as many as nine different health care centers over the
years. Although the most prevalent pathogens isolated
among Cambodian patients were influenza, dengue and
malaria, the studies also identified diseases such as lep-
tospirosis, hantavirus and hepatitis A, B and E, as well
as diseases caused by rickettsial infections. Bacterial
organisms collected from these studies were analyzed
for antimicrobial resistance. The surveillance also identi-
fied the first cases of multidrug-resistant Salmonella
typhi with reduced susceptibility to fluoroquinolones in
Cambodia [2].
Another NAMRU-2 effort, the Indonesian Pediatric
Diarrhea Surveillance program, links six distinct geo-
graphic sites on five islands of the Indonesian archipe-
lago. The ongoing multi-year collaborative effort has
collected more than 12,000 specimens from patients
with acute diarrhea symptoms. Bacterial pathogens were
identified in 1,142 cases (11 percent), with Campylobac-
ter and Shigella species being the most prevalent etiolo-
gies isolated. Vibrio cholerae was the most common
Vibrio species identified. Shigellosis was identified as the
cause of diarrhea in 300 (2 percent) of the cases. Anti-
microbial susceptibility testing of Shigella samples
demonstrated very high levels of resistance to trimetho-
prim-sulfamethoxazole, often used as the first-line anti-
biotic to treat children with diarrhea in Indonesia [3].
Campylobacter species were identified in 314 cases of
children presenting with diarrhea to participating hospi-
tals and health clinics in Jakarta, Makassar and Mataram.
Antimicrobial susceptibility testing to C. jejuni identified
rates of ciprofloxacin resistance as high as 65 percent
with several cases exhibiting macrolide resistance. Similar
patterns were observed for isolates of C. coli. An increase
in minimum inhibitory concentrations (MIC) for several
antibiotics, including ciprofloxacin, was found when ana-
lyzing results over the time span of specimen collections.
NAMRU-2 implemented a real-time polymerase chain
reaction (PCR) assay to discriminate between Campylo-
bacter isolate wild-type and mutant alleles that can con-
fer resistance to fluoroquinolones. The study found the
majority of resistant isolates possessed this mutation.
Several strains that were negative by PCR but resistant by
MIC testing are being further characterized by sequence
analysis of the quinolone resistance-determining region
in an attempt to identify other novel mutations that may
confer resistance [3].
Cholera surveillance
Investigators at the U.S. Armed Forces Research Institute
of Medical Sciences (AFRIMS) responded to a large out-
break of severe diarrhea that affected over 70,000 people
in 2009. They found 52 percent of the 158 samples were
positive for Vibrio cholera strain O1, 18 percent
were heat-labile toxin-expressing ETEC and 13 percent
were heat-stable toxin-expressing ETEC. All V. cholerae
strains isolated from the outbreak were resistant to nali-
dixic acid and trimethoprim-sulfamethoxazole, but they
were sensitive to tetracycline, ciprofloxacin, norfloxacin
and ampicillin [4].
The V. cholerae and rotavirus reference center for the
Middle East and Africa established by the U.S. Naval
Medical Research Unit Number 3 (NAMRU-3) per-
formed antibiotic sensitivity testing of 303 archived
V. cholerae samples. The center’s studies demonstrate
widespread resistance to streptomycin, trimethoprim-
sulfamethoxazole and nalidixic acid. Resistance to ampi-
cillin and chloramphenicol was observed only in isolates
from Somalia, and resistance to tetracycline was limited
to single isolates from Qatar and Somalia [5].
Health care-associated pathogens
Health care-associated infections and antimicrobial
resistance have emerged as important public health pro-
blems in both developed and resource-poor countries,
as well as among DoD personnel. Increased surveillance
in hospitals in developing countries may determine risk
factors (e.g., overuse of antibiotics, counterfeit drugs or
deficiencies in local patient management guidelines and
policies) that are different from those in developed
countries. This may also define high-risk medical prac-
tices and enable the hospitals to tailor and implement
intervention plans to reduce infection rates in resource-
limited settings. These surveillance activities may
become examples that other developing countries can
follow in their attempts to reduce nosocomial infection
rates and increase the safety of health care systems in
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quently. Furthermore, knowledge about the genetic
determinants of antimicrobial resistance can be very
important for tailoring antibiotic policies and tracing the
nosocomial spread of pathogens. Molecular characteriza-
tion studies are essential tools that may help reduce
nosocomial infection mortality rates and the cost of
treating antibiotic-resistant infections, and limit inap-
propriate antibiotic use.
More than 30,000 U.S. military personnel have been
wounded in action while serving in Iraq or Afghanistan
[6], and many of these patients are at risk for serious
complications. Wound infections have been a common
complication of these injuries and, as in previous wars,
are often caused by gram-negative organisms. Minimal
information is available about the mechanism of antimi-
crobial resistance of bacterial infections in Middle
Eastern countries. Working with various regional host-
nation partners, the laboratories have been able to docu-
ment the geographic spread of antimicrobial resistance
in common organisms. This vital information is used to
effectively advise local and national health care leaders
about necessary changes to antimicrobial formularies
and provides important information on appropriate anti-
biotic treatment for troops deployed in the Middle East
[7]. Extended spectrum beta-lactamase-producing gram-
negative rods and Acinetobacter baumannii are major
causes of infections in health care settings. Many of
these nosocomial infections are difficult to treat with
antibiotics, and the antibiotic-resistant organisms that
cause them are increasingly being seen in community-
acquired infections [8].
In Egypt and Jordan, NAMRU-3 has been engaged in
surveillance of health care-acquired infections and anti-
microbial resistance with emphasis on intensive care
units [9]. Researchers analyzed 124 highly resistant
gram-negative rods that were collected as part of this
surveillance network. Isolates were characterized pheno-
typically by standard bacteriological procedures and
antimicrobial susceptibility profiles were obtained using
Clinical and Laboratory Standards Institute (CLSI) cri-
teria. Major mechanisms of antimicrobial resistance in
isolates confirmed as either extended-spectrum beta-
lactamase-producing bacteria or Acinetobacter bauman-
nii were further characterized by pulsed-field gel
electrophoresis (PFGE), plasmid profiling, PCR amplifica-
tion and DNA sequencing.
The resulting antimicrobial resistance profile classified
46 (37 percent) of the isolates as multidrug-resistant
organisms. Nineteen isolates (15 percent) were resistant
to imipenem and 20 (16 percent) were resistant to mer-
openem. Sixteen isolates (13 percent) were resistant to
both carbapenems. All isolates were sensitive to colistin
and were also sensitive or intermediately sensitive to
minocycline. Antimicrobial resistance testing using the
Etest
® strip method indicated production of metallo-
beta-lactamase in 18 (14 percent) of isolates.
The NAMRU-3 surveillance of health care-acquired
infections and antimicrobial resistance demonstrated that
gram-negative organisms constituted the majority of iso-
lates in both countries (61 percent in Egypt and 65.2 per-
cent in Jordan) [8]. In Jordan, Klebsiella species were the
most commonly isolated gram-negative pathogens
(17.4 percent of all isolates), whereas in Egypt, Klebsiella
species and A. baumannii were equally prevalent among
the gram-negative bacilli with each organism accounting
for 15.4 percent of the isolates. Not surprisingly, high rates
of antimicrobial resistance were reported in hospitals in
both countries. Extended-spectrum beta-lactamase produ-
cer rates among E. coli isolates were 64.3 and 66.7 percent
in Egypt and Jordan, respectively. Klebsiella species
showed extended-spectrum beta-lactamase producer rates
of 57.1 percent in Egypt and 75 percent in Jordan.
In Egypt, resistance of Pseudomonas aeruginosa to imipe-
nem was 58.8 percent, and almost 88 percent of Staphylo-
coccus aureus isolates were resistant to methicillin.
The higher rates of antimicrobial resistance in specific
intensive-care units (ICUs) encourage the establishment of
better-informed antimicrobial use policies and implemen-
tation of stricter infection control practices. These mitiga-
tions help decrease antimicrobial resistance rates and
reduce the risk of spread to the community.
Acinetobacter infections
Antimicrobial-resistant strains of bacteria threaten U.S.
military personnel deployed in the Middle East and
Afghanistan from combat- and non-combat-related
infections caused by these highly resistant pathogens
[10]. Acinetobacter baumannii-calcoaceticus complex,
P. aeruginosa, Klebsiella and E. coli are common
pathogens, but, compared to past wars, the acquisition
of multidrug-resistant isolates appears to be signifi-
cantly increased [11]. A. baumannii is a common
nosocomial challenge in Egypt and has emerged as one
of the important opportunistic pathogens in hospita-
lized patients throughout the world. Additionally, these
infections plague DoD and Veterans Affairs medical
treatment facilities and contribute to prolonged hospi-
tal stays. Outbreaks of Acinetobacter infections are
becoming increasingly common among patients in
ICUs, surgical units and burn units [12].
The severe impact of an Acinetobacter outbreak on
hospital operations requires a quick assessment of the
potential spread of these infections. Comparison of
A. baumannii PFGE patterns from Egypt with isolates
collected at military treatment facilities in the U.S.
showed high levels of genetic variability among collec-
tions. The majority of the Acinetobacter isolates cultured
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drug-resistant, limiting the use of some empiric antibio-
tics for treatment of wound infections [11].
Continuous surveillance with genetic characterization
of Acinetobacter is the ideal method to direct infection-
control measures or altering of antimicrobial regimens.
Molecular genotyping of these isolates enhances infec-
tion control of personnel wounded in the Middle East
and the possible nosocomial transmission of these
organisms within the DoD hospital system. Characteri-
zation of the multi-drug resistant organisms via PFGE
genotyping will help identify possible sources of infec-
tion and lead to strategies for employing appropriate
antibiotics and isolation practices.
Landstuhl Regional Medical Center (LRMC) has an
active surveillance protocol for A. baumannii.A l l
incoming patients from Operation Iraqi Freedom,
Operation Enduring Freedom and Africa are screened
for colonization of Acinetobacter. Between October
2008 and March 2009, more than 500 A. baumannii iso-
lates were processed. Three main clusters of 90 percent
similarity were identified and account for 66 percent of
the strains examined. This comparison of Acinetobacter
genotypes significantly benefits infection control efforts
by helping identify potential sources of spread, particu-
larly those that occur during the evacuation chain from
the battlefield to U.S.-based hospitals. This genotyping
data has been used for infectious disease surveillance
and infection control at LRMC and thereby improved
total patient care.
In January 2009, an increase in the number of
A. baumannii infections with similar antibiograms in
t h eL R M CI C Uw a so b s e r v e d[ 1 3 ] .T h et h r e es t r a i n s
were shown to be genotypically similar. While the actual
source was not determined, the infection control team
adopted additional measures, and further spread did not
occur. The data from the Acinetobacter studies, includ-
ing the PFGE, antibiotic susceptibility and plasmid pro-
filing, will provide valuable information regarding the
epidemiology and evolution of A. baumannii from the
onset of Operation Iraqi Freedom.
Collection of this data allows researchers to identify
strains of interest for further detailed molecular work
(e.g., genome sequencing). The PFGE data collected at
LRMC is shared with other military treatment facilities.
The DiversiLab and PFGE data generated at LRMC
allow AFHSC-GEIS and DoD to make more informed
funding decisions by comparing the two systems in
terms of cost, ease of use and quality of data.
A unique three-year collaborative effort championed
by Dr. Luther Lindler, the GEIS Acinetobacter Surveil-
lance Initiative, established standard operating proce-
dures for PFGE of Acinetobacter species among
laboratories at Brooke Army Medical Center (BAMC),
Walter Reed Army Institute of Research (WRAIR),
Walter Reed Army Medical Center and LRMC. Some of
the samples processed were sent to BAMC and WRAIR
for comparison with the samples of all participating
military treatment facilities. Some samples processed by
each of the partner laboratories were sent to BAMC and
WRAIR for analysis, generating a systematic collection
of PFGE patterns-identified strains infecting DoD per-
sonnel. This enhanced the capabilities of DoD to deter-
mine the initial geographic location of contamination as
well as the spread and prevention of virulent strains of
gram-negative organisms originating from wound infec-
tions. Specific isolate information coupled with patient
outcomes led to the identification of specific virulence
factors within particularly virulent strains and guides the
use of specific or novel antibiotic treatments [14].
Drug resistance studies at Brook Army Medical Center
The primary objective of the Center of Excellence for
Leptospirosis at BAMC is developing reliable molecular
diagnostic techniques based on PCR for the disease. The
center has also assessed the antimicrobial therapies for
leptospirosis using in vitro and in vivo models. After
developing a calorimetric system to test antimicrobial
resistance by an in vitro model to various leptospiral
strains from around the world, the center has continued
to collect novel strains from around the world to test
while assessing a broad array of serovars against older
and newer antimicrobial agents.
Antimicrobial agents that have been tested to date
include older agents such as amikacin, cefazolin, ceftazi-
dime, cephalexin, colistin, fosfomycin, gentamicin,
metronidazole, minocycline, polymyxin, rifampin, sulfa-
methoxazole, tobramycin, trimethoprim, imipenem, and
vancomycin [15-18]. Newer and novel agents including
tigecycline, doripenem, cethromycin, CEM-101 and
CEM-102 also have been tested. In addition, the more
active in vitro antimicrobial agents have been character-
ized further in a lethal hamster model for in vivo activ-
ity. This work has enabled the center to respond to
specific requests by clinicians in the developing world to
determine if older more commonly used antimicrobials
not used in the U.S., such as chloramphenicol, have
activity.
Additionally, BAMC has maintained a referral labora-
tory at the San Antonio Military Medical Center (Texas)
to support DoD outbreak investigations and other epide-
miological investigations and research. This center pro-
vides centralized molecular biology support to
characterize multidrug-resistant bacteria pathogens and
has been involved in multiple studies. BAMC developed
a collaborative research relationship with Fort Sill
(Oklahoma) to support a methicillin-resistant Staphylo-
coccus aureus (MRSA) colonization study supported
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Research Program-sponsored project of chlorhexidine-
impregnated cloths to prevent skin and soft tissue infec-
tions in U.S. Marine officer candidates. Additionally, they
performed resistance and virulence factor gene analysis
for Klebsiella pneumonia and developed and analyzed
numerous multidrug-resista n tp a t h o g e n sa n dp o s s i b l e
outbreaks including analysis of MRSA isolates recovered
from the U.S. Army Institute of Surgical Research burn
unit during the past 25 years [19,20].
Further studies at BAMC evaluated the resistance
mechanisms of Enterobacteriaceae as well as extended-
spectrum beta-lactamase-producing Klebsiella isolates
and their impact within a burn unit. They also studied
the efficacy of topical agents for Klebsiella, Pseudomo-
nas, MRSA, and Acinetobacter baumannii-calcoaceticus
complex in the burn unit [21,22]. These projects
included the study of multidrug-resistant Klebsiella,
Acinetobacter baumannii-calcoaceticus,a n dPseudomo-
nas infections over time within a patient and between
patients. A major focus of the BAMC group is to further
characterize antimicrobial activity against Acinetobacter
baumannii-calcoaceticus complex [23].
Clinical laboratory testing methods and broth microdi-
lution were used to define the susceptibility phenotypes
of 107 single-patient isolates from blood and wound
infections to 15 antimicrobial agents. Genetic relation-
ships were determined by PFGE, and isolates were
screened for selected resistance determinants. The iso-
lates were resistant to an average of nine agents and
four antimicrobial classes, with 92 percent meeting a
definition of multidrug-resistance.
The most active agents were colistin (MIC90 0.5 µg/mL,
99 percent susceptible) and minocycline (MIC90 4 µg/mL,
90 percent susceptible). Carbapenems, traditionally reserved
for multidrug-resistant infections, were relatively inactive
(imipenem MIC90 0.5 µg/mL, 38 percent S). Fifty-two per-
cent of isolates carried the OXA-23 carbapenemase, which
substantially degraded the activity of imipenem (78.4 per-
cent S without, versus 1.8 percent S with OXA-23 present).
Rifampin has promising in vitro activity (MIC90 4 µg/mL);
however, no susceptibility breakpoints have been defined.
Aminoglycosides also had very limited activity (amikacin
MIC90 ≥ 256 µg/mL, 16.8 precent S; gentamicin MIC90
≥32 µg/mL, 4.7 percent S; tobramycin MIC90 ≥ 32 µg/mL,
27.1 percent S). Aminoglycoside-modifying enzymes were
heterogeneous in these isolates, and poorly predictive of the
aminoglycoside susceptibility phenotype.
Nearly half (49.5 percent) of the isolates carried the
class 1 integron, a marker for the acquisition of cassettes
containing multiple antimicrobial resistance genes. Of
107 isolates, 106 (99 percent) carried at least one resis-
tance determinant. Significant inaccuracies were found
in some clinical testing methods for tetracyclines,
aminoglycosides and, to a lesser extent, carbapenems.
Identifying the most prevalent resistance mechanisms,
optimal susceptibility testing and judicious use of anti-
microbial agents may help preserve the last remaining
agents with activity against multidrug-resistant bacteria.
Overall these projects have enabled BAMC to leverage
its various programs to collaborate with internal and
external partners to improve treatment of combat-
related injury infections and multi-drug resistant infec-
tions by assessing local delivery of antibiotics in animal
models and characterizing novel resistant bacteria. It has
also enabled better characterization of multi-drug-
resistant infection rates throughout the military health
care system from point of injury through tertiary care
referral hospitals in the U.S.
Antimicrobial resistance in military trainee populations
Another ongoing AFHSC-GEIS-supported activity at
Naval Health Research Center (NHRC), San Diego,
characterizes the clinical isolates of Streptococcus pyo-
genes from U.S. military basic trainees [24]. Group A
S. pyogenes (GAS) infections are common in young
adults and may present clinically as pharyngitis, scarlet
fever or invasive disease. GAS is also associated with
post-infectious sequelae, including rheumatic heart dis-
ease and glomerulonephritis. Acute GAS infections
remain susceptible to penicillin but resistance to macro-
lide antibiotics has been noted in recent years.
Antibiotics are frequently used for prophylaxis of
recruits against infections; therefore characterization of
GAS isolates is necessary in these populations. Ongoing
surveillance since 1998 has demonstrated continued sus-
ceptibility to penicillin and low-level resistance to
macrolides and other antibiotics in GAS isolates col-
lected at nine recruit training sites.
Macrolide resistance is of particular concern because
this class of antibiotics is often used for prophylaxis and
treatment of individuals who are allergic to penicillin.
NHRC tested 2,837 GAS isolates from recruits since the
study’s inception in 1998. Among 240 isolates collected
in 2009, in comparison with previous annual studies,
lower resistance was seen with erythromycin (6.6 per-
cent), while higher resistance was seen for tetracycline
(7.0 percent), clindamycin (4.3 percent), and levofloxacin
(6.5 percent). Higher levofloxacin resistance was seen in
2009 at Marine Corps Recruit Depot, Parris Island
(South Carolina) and higher clindamycin, erythromycin
and tetracycline resistance was seen at Fort Benning
(Georgia). Additionally, M protein gene (emm) typing of
S. pyogenes performed by NHRC has demonstrated asso-
ciations of certain emm types to resistance and viru-
lence. Other emm types have been shown to be more
likely associated with outbreaks among U.S. military
trainees.
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emergence of potentially virulent strains could lead to
early interventions that may prevent outbreaks and
reduce morbidity. The most common emm gene types
among trainees were 3, 5, 44, 6 and 75. Emm type
75 was associated with increased levels of erythromycin
resistance, but without apparent increased virulence.
Emm type 5 was less common but is one of the poten-
tially more virulent strains and was implicated in several
outbreaks in 2006 and 2007. A high degree of correla-
tion exists in the temporal distribution of strain patterns
between multiple sites suggesting a concerted strain
turnover pattern occurring on a larger scale.
These results demonstrated the sensitivity and specifi-
city of a recently developed, rapid, high-throughput
strain identification technology and provided the basis
for a method of rapid inferential prediction of clinically
relevant characteristics using rapid strain typing meth-
ods. This surveillance also provided information on cir-
culating strains for GAS vaccine development initiatives.
Electronic surveillance of antimicrobial resistance
A completely different approach using electronic data
sources for antimicrobial resistance surveillance was
undertaken by the Navy Marine Corps Public Health
Center (NMCPHC). NMCPHC developed algorithms
and tools to interpret Health Level 7 (HL7) data derived
from the DoD Composite Health Care System for sur-
veillance of diseases significant to public health [25].
U s eo ft h i sd a t af o rt h es u r v e i l l a n c eo fa n t i b i o t i cr e s i s -
tance feeds data into BacLink and WHONET, tools
developed by the World Health Organization (WHO).
Using its experience with inpatient and outpatient
encounter records, laboratory and pharmacy data, and
other medical and personnel databases, NMCPHC
explored trends in diseaseb u r d e na n da n t i b i o t i c -
resistant microorganisms.
The DoD-wide HL7 electronic microbiology labora-
tory data were restructured to rapidly identify and
monitor emerging antimicrobial resistance in organisms,
such as A.baumannii, K. pneumoniae, P. aeruginosa and
other pathogens of public health concern. The HL7 data
stream provides an opportunity for active surveillance of
trends in antibiotic resistance and near-real-time
response to significant health threats, especially in high-
risk populations.
These capabilities were used to enhance surveillance
and understanding of trends in emerging pathogens and
antibiotic resistance as well as to answer requests for
information about invasive MRSA and S. pneumoniae in
the Military Health System beneficiary population and
describe skin and soft tissue infections among DoD
members. More than 175,000 skin and soft tissue cases
were identified among DoD active-duty military service
member medical encounters between October 2006 and
May 2008.
Seventy-four percent of cultured skin and soft tissue
infection cases were associated with S. aureus, followed
by coagulase-negative Staphylococcus (6 percent), E. coli
(2 percent), P. aeruginosa (1 percent) and Proteus mir-
abilis (1 percent). More than half of the S. aureus iso-
lates tested for oxacillin sensitivity were defined as
MRSA. MRSA isolates were not only resistant to oxacil-
lin but also to erythromycin (90 percent). Methicillin-
sensitive S. aureus (MSSA) isolates were sensitive to
other commonly-used antibiotics, including trimetho-
prim-sulfamethoxazole and vancomycin. HL7 outpatient
pharmacy data showed that the antibiotics used to treat
both types of infection were very similar; trimethoprim-
sulfamethoxazole was prescribed frequently for both
MRSA (67 percent) and MSSA (52 percent).
The first iteration of an NMCPHC antimicrobial-
resistant organism surveillance website displays antibio-
grams and high-profile organism counts, as well as similar
data broken out by service and region [26]. The project
includes the use of WHONET to generate facility-specific,
DoD-wide and regional antibiograms for comparison and
assessment of trends external to their own patient popula-
tions. The methodology used to restructure antimicrobial
data was validated by comparing the sensitivity profiles
prepared by military treatment facilities to the NMCPHC
sensitivity profiles from the restructured data. The valida-
tion process is ongoing.
The importance of electronic surveillance is demon-
strated further in the NMCPHC analysis of the study,
Acinetobacter species Infections: Trends in Active-Duty
Servicemembers. The investigation identified more than
6,300 Acinetobacter isolates found in 2,467 DoD active-
duty servicemembers between 2005 and 2008. Acineto-
bacter species isolates from wound specimens made up
34 percent of active-duty servicemember isolates
(n=2,138) and showed levels of susceptibility between
45 percent and 80 percent to all of the commonly pre-
scribed antibiotics reviewed throughout the study time
period; 95 percent of these isolates were Acinetobacter
baumannii-calcoaceticus complex [25].
Isolates identified from blood specimens made up
6.5 percent of all active-duty service member isolates
(n=409). Overall susceptibility of these isolates to amika-
cin was 36 percent, imipenem susceptibility was 57 per-
cent and colistin susceptibility was 33 percent.
Meropenem results for these isolates were quite limited,
with only 15 isolates tested and an overall susceptibility
of 7 percent [25].
A similar electronic study of upper respiratory infec-
tions and antibiotic resistance among U.S. Navy recruits
with upper respiratory infection-associated medical
encounters and microbiology records document
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nosa in 3 percent of 1,022 laboratory specimens [25].
Future direction and initiatives
Since the inception of DoD-GEIS and now AFHSC-
GEIS, multiple partners have studied various aspects of
antimicrobial resistance with a multitude of methods.
This section documents the 2009 partner accomplish-
ments and activities.
The increasing prevalence of emerging antimicrobial-
resistant infections remains one of the greatest threats to
global health and will continue to be a major concern for
AFHSC-GEIS. To successfully counter this threat, the
global network will need to be united and coordinated.
The three-year GEIS Acinetobacter Surveillance Initiative
demonstrated the value of standardized operating proce-
dures and central specimen archives in expanding the
knowledge base for these unique, but all too common,
infections. AFHSC-GEIS-funded partners will need to
develop closer collaborations to best understand the var-
ious components involved with global antibiotic-resistant
organism surveillance. AFHSC-GEIS has begun initiatives
such as subject matter expert steering committees to bet-
ter direct and coordinate funded proposals as a means of
identifying surveillance gaps, avoiding redundancies and
assuring state-of-the art technologies.
The creation of an Antimicrobial-Resistant Organism
Steering Committee is planned for fiscal year 2011 and
will help develop a unified global surveillance plan to
combat this common enemy. Increased and sustained
surveillance capabilities that can rapidly identify genetic
and phenotypic patterns of resistance are essential tools
for surveillance in the ever-changing field of microbiol-
ogy and antimicrobial resistance.
The ability to track antimicrobial resistance in organ-
isms causing disease in DoD beneficiaries is essential for
infectious disease and public health leaders to formulate
policy and determine appropriate actions for mitigation.
AFHSC-GEIS will continue to fund studies that increase
its knowledge of the forces and mechanisms that create
resistant organisms so that the battle against antimicro-
bial resistance can be waged more effectively.
Conclusion
Infectious diseases have always been a major threat to
U.S. military forces and global public health. Antimicro-
bial resistance surveillance has been a pillar of military
force health protection and global public health for
AFHSC-GEIS since its creation in 1998. AFHSC-GEIS
funding has enhanced the ability of partner laboratories
to maintain robust infectious disease surveillance.
A significant spin-off of these efforts is the acquisition
of multiple isolates of microorganisms infecting patients
from various regions of the world which can be further
analyzed for antimicrobial resistance. The rate and
spread of antimicrobial resistance can be tracked and
helps to direct patient care, antibiotic prescribing prac-
tices and national policy.
To better understand the global picture of infectious
disease, it is essential to use standardized nomenclature
and laboratory procedures in order to correctly identify
the causative microorganisms. Additionally, the various
reports must be collated if the data is to be relevant to
DoD populations spread around the world. AFHSC-
GEIS-funded partners have continued to contribute
greatly to essential research and development of techni-
ques that further the investigation of disease causing
organisms. Rapidly changing technologies and computer
applications speedt h ep r o c e s so fa n a l y s i so ft h eo r g a n -
isms and allow more educated and informed policies
and interventions to better treat and prevent infectious
disease threats. This report has provided a synopsis of
recent antimicrobial resistance surveillance accomplish-
ments achieved by AFHSC-GEIS partners.
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